CS logo
small CS logo
Tver Regional Clinical Hospital

Tver, Russian Federation
University in Tver
Ulitsa Sovetskaya, 4, Tver, Tver Oblast, 170100

About Tver Regional Clinical Hospital


Tver State Medical University is a research, scientific and educational center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Supergene, LLC
4
Actelion
2
Boehringer Ingelheim
1
Hospital do Coracao
1
Total Rows: 5

Clinical Trials at Tver Regional Clinical Hospital


During the past decade, Tver Regional Clinical Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11004422002211110000000000220000Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
2015-08-01
2019-01-01
Completed
3,799
Single Bolus Recombinant Nonimmunogenic Staphylokinase (FORtelyzin) Versus Single Bolus Tenecteplase (Metalyse) in STEMI
2014-10-01
2016-12-01
Unknown status
392
Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS
2017-03-18
2019-06-20
Completed
336
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
2017-07-12
2020-11-10
Completed
741
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
2017-07-21
2023-10-01
Active, not recruiting
171
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
2017-07-05
2024-01-18
Active, not recruiting
877
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-11-20
2021-11-15
Completed
214
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
2018-08-15
2019-10-04
Completed
4,819

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tver Regional Clinical Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Supergene, LLC" with 4 trials sponsored, "Actelion" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Hospital do Coracao" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4Supergene, LLC: 4Supergene, LLC: 4Actelion: 2Actelion: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Hospital do Coracao: 1Hospital do Coracao: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tver Regional Clinical Hospital


According to Clinical.Site data, the most researched conditions in "Tver Regional Clinical Hospital" are "Arthritis, Psoriatic" (2 trials), "Acute Limb Ischemia" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Colitis, Ulcerative" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Tver Regional Clinical Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Tver Regional Clinical Hospital


Most popular intervention types in "Tver Regional Clinical Hospital" are "Drug" (12 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Alteplase" (2 trials), "Guselkumab" (2 trials), "Recombinant staphylokinase" (2 trials) and "Canagliflozin 100 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tver Regional Clinical Hospital


The vast majority of trials in "Tver Regional Clinical Hospital" are 12 trials for "All" genders.

Clinical Trials Status at Tver Regional Clinical Hospital


Currently, there are NaN active trials in "Tver Regional Clinical Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tver Regional Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tver Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 4Recruiting: 4Active, not recruiting: 2Active, not recruiting: 2Unknown status: 1Unknown status: 1